Aclaris Therapeutics Inc (ACRS)

May 21, 2025

Common Warts Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Verrica Pharma, Kino Pharma, Iwaki Pharma, Aclaris Therapeutics, KinoPharma Inc - The Globe and Mail

May 21, 2025

May 21, 2025

Brokerages Set Aclaris Therapeutics, Inc. (NASDAQ:ACRS) PT at $10.00 - Defense World

May 21, 2025

May 18, 2025

HC Wainwright Has Positive Forecast for ACRS Q3 Earnings - Defense World

May 18, 2025

May 17, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Holdings Raised by Dimensional Fund Advisors LP - Defense World

May 17, 2025

May 16, 2025

Aclaris Therapeutics to Host Virtual Fireside Chat with CEO Neal Walker on May 16, 2025 - MSN

May 16, 2025

May 16, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Stake Reduced by Price T Rowe Associates Inc. MD - Defense World

May 16, 2025

May 14, 2025

Aclaris Therapeutics (ACRS) Price Target Update by HC Wainwright & Co. | ACRS Stock News - GuruFocus

May 14, 2025

May 14, 2025

Aclaris Therapeutics (ACRS) Receives Lower Price Target from Ana - GuruFocus

May 14, 2025

May 14, 2025

Aclaris Therapeutics Reports Q1 2025 Financial Results - MSN

May 14, 2025

May 13, 2025

Androgenetic alopecia Pipeline 2025: Groundbreaking Clinical - openPR.com

May 13, 2025

May 12, 2025

Aclaris Therapeutics Reports Q1 2025 Results and Pipeline Updates - MSN

May 12, 2025

May 12, 2025

Aclaris Therapeutics Welcomes Dr. Jesse Hall as Chief Medical Officer - MSN

May 12, 2025

May 11, 2025

Scotiabank Has Lowered Expectations for Aclaris Therapeutics (NASDAQ:ACRS) Stock Price - Defense World

May 11, 2025

May 10, 2025

Aclaris Therapeutics (ACRS) Price Target Lowered by Scotiabank | - GuruFocus

May 10, 2025

May 10, 2025

Aclaris Therapeutics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

May 10, 2025

May 10, 2025

Raymond James Financial Inc. Purchases New Holdings in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

May 10, 2025

May 10, 2025

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series - GlobeNewswire

May 10, 2025

May 10, 2025

Scotiabank Adjusts Price Target for Aclaris Therapeutics (ACRS) - GuruFocus

May 10, 2025

May 09, 2025

Aclaris Therapeutics to Participate in the HC Wainwright 'HCW@Home” Series - The Manila Times

May 09, 2025

May 09, 2025

Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series - GlobeNewswire Inc.

May 09, 2025

May 09, 2025

Mariner LLC Sells 10,327 Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

May 09, 2025

May 09, 2025

Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 09, 2025

May 09, 2025

Aclaris: Q1 Earnings Snapshot - CT Insider

May 09, 2025

May 08, 2025

Aclaris Therapeutics Inc earnings beat by $0.02, revenue fell short of estimates - Investing.com India

May 08, 2025

May 08, 2025

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 08, 2025

May 08, 2025

Aclaris Therapeutics Reports Q1 2025 Financial Results and Corporate Update with Focus on Immuno-Inflammatory Developments and Extended Cash Runway through 2028 - Nasdaq

May 08, 2025

May 08, 2025

Aclaris Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

Hims & Hers Has a Superpower in Healthcare - The Globe and Mail

May 08, 2025

May 08, 2025

Here's Why I'm Still Buying SoFi Hand Over Fist in 2025 - The Globe and Mail

May 08, 2025

May 07, 2025

Aclaris Therapeutics Inc (ACRS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

May 07, 2025

May 06, 2025

Invesco Ltd. Invests $28,000 in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

May 06, 2025

May 04, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 04, 2025

Apr 30, 2025

Geode Capital Management LLC Reduces Stake in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

Apr 30, 2025

Apr 30, 2025

XTX Topco Ltd Acquires New Position in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) - Defense World

Apr 30, 2025

Apr 30, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Short Interest Down 34.8% in April - Defense World

Apr 30, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

Aclaris Therapeutics Names Jesse Hall Chief Medical Officer - marketscreener.com

Apr 29, 2025

Apr 29, 2025

Aclaris Therapeutics (ACRS) Welcomes Jesse Hall as Chief Medical Officer | ACRS Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer - marketscreener.com

Apr 29, 2025

Apr 29, 2025

Aclaris Therapeutics appoints new Chief Medical Officer - Investing.com

Apr 29, 2025

Apr 29, 2025

Aclaris Strengthens Leadership: Humira and Prolia Developer Takes CMO Role to Advance Immunology Pipeline - Stock Titan

Apr 29, 2025

Apr 29, 2025

Androgenetic Alopecia Treatment Market Generated - openPR.com

Apr 29, 2025

Apr 26, 2025

Aclaris Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Apr 26, 2025